Rubicon Biotechnology, a drug development company, is focused on the development of novel biologics for indications in cardiovascular, oncology and medical defense countermeasures. Rubicon's core group of experts contracts with highly specialized consultants, CROs, and CMOs for product development and clinical studies on a product-by-product basis. Rubicons goal is to develop products to meet the expectations of large pharma with respect to efficacy and safety data, process sciences and cGMP production, supply chain COGs, and regulatory submissions.
